213 related articles for article (PubMed ID: 29381230)
1. Novel SYNGAP1 variant in a patient with intellectual disability and distinctive dysmorphisms.
Kimura Y; Akahira-Azuma M; Harada N; Enomoto Y; Tsurusaki Y; Kurosawa K
Congenit Anom (Kyoto); 2018 Nov; 58(6):188-190. PubMed ID: 29381230
[TBL] [Abstract][Full Text] [Related]
2. Molecular and phenotypical findings of a novel de novo SYNGAP1 gene variant in an 11-year-old Iranian boy with intellectual disability.
Mir A; Song Y; Lee H; Nadeali Z; Akbarian F; Tabatabaiefar MA
Lab Med; 2024 Mar; 55(2):204-208. PubMed ID: 37467311
[TBL] [Abstract][Full Text] [Related]
3. De novo, heterozygous, loss-of-function mutations in SYNGAP1 cause a syndromic form of intellectual disability.
Parker MJ; Fryer AE; Shears DJ; Lachlan KL; McKee SA; Magee AC; Mohammed S; Vasudevan PC; Park SM; Benoit V; Lederer D; Maystadt I; Study D; FitzPatrick DR
Am J Med Genet A; 2015 Oct; 167A(10):2231-7. PubMed ID: 26079862
[TBL] [Abstract][Full Text] [Related]
4. Analysis of 31-year-old patient with SYNGAP1 gene defect points to importance of variants in broader splice regions and reveals developmental trajectory of SYNGAP1-associated phenotype: case report.
Prchalova D; Havlovicova M; Sterbova K; Stranecky V; Hancarova M; Sedlacek Z
BMC Med Genet; 2017 Jun; 18(1):62. PubMed ID: 28576131
[TBL] [Abstract][Full Text] [Related]
5. Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency.
Berryer MH; Hamdan FF; Klitten LL; Møller RS; Carmant L; Schwartzentruber J; Patry L; Dobrzeniecka S; Rochefort D; Neugnot-Cerioli M; Lacaille JC; Niu Z; Eng CM; Yang Y; Palardy S; Belhumeur C; Rouleau GA; Tommerup N; Immken L; Beauchamp MH; Patel GS; Majewski J; Tarnopolsky MA; Scheffzek K; Hjalgrim H; Michaud JL; Di Cristo G
Hum Mutat; 2013 Feb; 34(2):385-94. PubMed ID: 23161826
[TBL] [Abstract][Full Text] [Related]
6. Novel Mutation of SYNGAP1 Associated with Autosomal Dominant Mental Retardation 5 in a Chinese Patient.
Pei Y; Li W; Du L; Wei F
Fetal Pediatr Pathol; 2018 Dec; 37(6):400-403. PubMed ID: 30572772
[TBL] [Abstract][Full Text] [Related]
7. Identification of an individual with a SYGNAP1 pathogenic mutation in India.
Verma V; Mandora A; Botre A; Clement JP
Mol Biol Rep; 2020 Nov; 47(11):9225-9234. PubMed ID: 33090308
[TBL] [Abstract][Full Text] [Related]
8. [Identification of a novel SYNGAP1 mutation in a child with intellectual disability].
Lu J; Zhang Y; Han C; Zhu J; Wang J; Yao R
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Jul; 36(7):716-719. PubMed ID: 31302919
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive phenotypes of patients with SYNGAP1-related disorder reveals high rates of epilepsy and autism.
Wiltrout K; Brimble E; Poduri A
Epilepsia; 2024 May; 65(5):1428-1438. PubMed ID: 38470175
[TBL] [Abstract][Full Text] [Related]
10. 6p21.3 microdeletion involving the SYNGAP1 gene in a patient with intellectual disability, seizures, and severe speech impairment.
Writzl K; Knegt AC
Am J Med Genet A; 2013 Jul; 161A(7):1682-5. PubMed ID: 23687080
[TBL] [Abstract][Full Text] [Related]
11. Lovastatin Treatment of a Patient with a
Cook EH; Masaki JT; Guter SJ; Najjar F
J Child Adolesc Psychopharmacol; 2019 May; 29(4):321-322. PubMed ID: 30901256
[No Abstract] [Full Text] [Related]
12. A novel de novo microdeletion spanning the SYNGAP1 gene on the short arm of chromosome 6 associated with mental retardation.
Krepischi AC; Rosenberg C; Costa SS; Crolla JA; Huang S; Vianna-Morgante AM
Am J Med Genet A; 2010 Sep; 152A(9):2376-8. PubMed ID: 20683986
[No Abstract] [Full Text] [Related]
13. [A case with autosomal dominant mental retardation type 5 due to de novo SYNGAP1 variant].
Gao Z; Lyu Y; Zhang K; Gao M; Ma J; Wang D; Gai Z; Liu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Jun; 37(6):661-664. PubMed ID: 32472547
[TBL] [Abstract][Full Text] [Related]
14. SYNGAP1 mutations: Clinical, genetic, and pathophysiological features.
Agarwal M; Johnston MV; Stafstrom CE
Int J Dev Neurosci; 2019 Nov; 78():65-76. PubMed ID: 31454529
[TBL] [Abstract][Full Text] [Related]
15. [A case of mental retardation caused by a frameshift variant of SYNGAP1 gene].
Shen Y; Luo G; Lu C; Tan Y; Cheng T; Qian X; Li N; Luo M; Cao Z; Ma X; Zhao Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Jan; 40(1):57-61. PubMed ID: 36585002
[TBL] [Abstract][Full Text] [Related]
16. Differential auditory brain response abnormalities in two intellectual disability conditions: SYNGAP1 mutations and Down syndrome.
Côté V; Knoth IS; Agbogba K; Vannasing P; Côté L; Major P; Michaud JL; Barlaam F; Lippé S
Clin Neurophysiol; 2021 Aug; 132(8):1802-1812. PubMed ID: 34130248
[TBL] [Abstract][Full Text] [Related]
17. SYNGAP1 Mutation in Focal and Generalized Epilepsy: A Literature Overview and A Case Report with Special Aspects of the EEG.
von Stülpnagel C; Funke C; Haberl C; Hörtnagel K; Jüngling J; Weber YG; Staudt M; Kluger G
Neuropediatrics; 2015 Aug; 46(4):287-91. PubMed ID: 26110312
[TBL] [Abstract][Full Text] [Related]
18. De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism.
Hamdan FF; Daoud H; Piton A; Gauthier J; Dobrzeniecka S; Krebs MO; Joober R; Lacaille JC; Nadeau A; Milunsky JM; Wang Z; Carmant L; Mottron L; Beauchamp MH; Rouleau GA; Michaud JL
Biol Psychiatry; 2011 May; 69(9):898-901. PubMed ID: 21237447
[TBL] [Abstract][Full Text] [Related]
19. A balanced translocation disrupts SYNGAP1 in a patient with intellectual disability, speech impairment, and epilepsy with myoclonic absences (EMA).
Klitten LL; Møller RS; Nikanorova M; Silahtaroglu A; Hjalgrim H; Tommerup N
Epilepsia; 2011 Dec; 52(12):e190-3. PubMed ID: 22050443
[TBL] [Abstract][Full Text] [Related]
20. Clinical and behavioural features of SYNGAP1-related intellectual disability: a parent and caregiver description.
Wright D; Kenny A; Eley S; McKechanie AG; Stanfield AC
J Neurodev Disord; 2022 Jun; 14(1):34. PubMed ID: 35655128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
